IMD Health Global and Pancreatic Cancer Canada announce partnership to improve the quality of patient education
July 21, 2022 – Toronto, Ontario
IMD Health Global (IMD) is pleased to announce an important new partnership with Pancreatic Cancer Canada. IMD is a CloudMD Software & Services company focused on digital health education, to provide resources to healthcare providers, patients and their families on the IMD platform.
“When it comes to a fast-moving disease like pancreatic cancer, patients and caregivers need disease-related resources to better understand their diagnosis and make informed treatment decisions at every stage of their journey. As the leading authority on pancreatic cancer in Canada, we are thrilled to partner with IMD Health to increase access to information for patients and healthcare providers,” said Jonathan Paul, Board Chair, Pancreatic Cancer Canada.
IMD Health is the largest digital health education platform in Canada. IMD offers innovative technology that facilitates meaningful dialogue between healthcare professionals and patients inside the examination room, hospital bedsides, pharmacy consultations and during virtual consultations. IMD’s award-winning platform enables healthcare professionals to instantly access over 110,000 media-rich educational graphics, videos and resources during consults as well as by patients at home.
“We are very excited to collaborate with Pancreatic Cancer Canada to provide our clinicians, patients and their families with trusted information to provide support to individuals with pancreatic cancer in Canada” said Alice Haidau, Medical Content Manager, IMD, citing the need for inclusive, evidence-based health information, particularly given the shift toward digital tools incited by the pandemic, and internet use which often leads to misinformation.
Through a resource like IMD, full of user-friendly and visually appealing information, healthcare providers, their patients and families will gain a better understanding of pancreatic cancer and its management.
About Pancreatic Cancer Canada
Pancreatic Cancer Canada is fighting to raise survival rates for the world’s toughest cancer by investing in targeted research, increased awareness and patient support, community activation and advocacy. We have taken on one of the world’s deadliest cancers — a disease with virtually no progress in survival in the past 40 years and a 90% mortality rate. We are aggressively fighting it with investments in research aimed at greater understanding of this cancer and better treatment options. At the same time, we are working to educate physicians about faster diagnosis and with patients/families to support them as they face the realities of this cancer at every stage.
Learn more at https://pancreaticcancercanada.ca/.
For more information, contact Ali Schofield, Director, Marketing and Communications, at email@example.com.
About IMD Health Global
IMD Health Global is a Toronto-based eHealth software development company, focused on innovating healthcare education. Since 2010, IMD has grown into Canada’s largest digital patient engagement platform. Centred “At The Point of Care” ®, healthcare professionals use IMD’s cloud-based platform (in clinic or virtual consults) to engage with their patients at a deeper level and optimize knowledge transfer surrounding a patient’s condition and treatment plan. This is done through the seamless integration of over 110,000 images, booklets, and video resources, (covering 5,600 health topics) into an award-winning user interface that makes patient education both efficient and effective. At the end of a patient’s consult, a summary of all the discussed information can be emailed to the patient to review and continue their learning journey at home, improving their health literacy and adherence to their treatment plan. The IMD platform is utilized by over 16,400 practitioners (doctors, nurses and pharmacists in, clinics, hospitals, pharmacies, infusion clinics and in homecare settings. For more information please visit: www.IMDhealth.com and https://app.IMDhealth.com IMD Health is a subsidiary of CloudMD Software & Services (TSXV: DOC)
For more information, contact Jared Sonnenberg, VP, at jared.sonnenberg@IMDhealth.com.
About CloudMD Software & Services
CloudMD is transforming the delivery of healthcare using technology and by providing a patient-centric approach, with an emphasis on continuity of care. By leveraging healthcare technology, the Company is building one, connected platform that addresses all points of a patient’s healthcare journey and provides better access to care and improved outcomes. Through CloudMD’s proprietary technology, the Company delivers quality healthcare through a holistic offering including hybrid primary care clinics, specialist care, telemedicine, mental health support, healthcare navigation, educational resources, and artificial intelligence (AI). CloudMD’s Enterprise Health Solutions Division includes the leading Student Assistance Program and one of the top 4 Employee Assistance Programs in Canada and offers one comprehensive, digitally connected platform for educational institutions, corporations, insurers, and advisors to better manage the health and wellness of their students, employees, and customers.
CloudMD currently services a combined ecosystem of over 7,000 psychiatrists, approximately 4,500 therapists and counsellors, approximately 4,000 psychologists, over 22,000 family physicians, over 34,000 medical specialists, over 1,500 allied health professionals, over 500 clinics, and over 5 million individuals across North America. For more information visit: https://investors.cloudmd.ca